Activation of wild-type p53 by MDM2 inhibitors: a new strategy for lymphoma treatment

Pujals A, Favre L, Gaulard P, Wiels J

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:93-100

Published Date: 29 July 2015